Archive ready
株式会社トランスジェニック 2024年事業計画
https://transgenic-group.co.jp/ir/library/business_plan/20240603-2.pdfMay 8, 2026 at 02:10 PM JST•The archive page, viewer, and downloads use this saved version.
May 8, 2026 at 02:10 PM JST·transgenic-group.co.jp
The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
Saved PDF
株式会社トランスジェニック 2024年事業計画
StartedMay 8, 2026 at 02:10 PM JST
File size4.58 MB
SHA-25653591b903a0ace818ede22c090324548ffd1843636fb7ed98313b5109a26c473
About this pageAI generated
This document outlines the business plan of TransGenic Inc. as of June 3, 2024, covering company overview, business model, market environment, growth strategy, and risk information. TransGenic operates in two main areas: drug discovery support and investment/consulting services, aiming for sustainable growth. The drug discovery support business utilizes cutting-edge biotechnology to provide seamless support from basic research to clinical trials. Additionally, the company plans to change its name to 'TransGenic Group Inc.' on October 1, 2024.